Effect of Vyaghrihareetaki Avaleha and Granules on Tamaka Shwasa (Bronchial Asthma)

Phase 2

Completed

• Conditions: Tamaka shwasaBronchial asthma

• Registration Number: CTRI/2011/12/002204
• Lead Sponsor: Institute for Post Graduate Teaching and Research in Ayurveda

Brief Summary

This study is an Open, Randomized, Controlled, Clinical study to evaluate the efficacy of Group A - Vyaghrihareetaki avaleha (jaggery based), Group B - Vyaghrihareetaki avaleha (sugar candy based), Group C - Vyaghrihareetaki granules (sugar candy based) in the management of Tamaka shwasa (Bronchial asthma). The primary outcome measures are Changes in signs and symptoms of Tamala shwasa, ACQ, ACT score, Respiratory rate, Breath holding time, PEFR changes before treatment and after 4 weeks.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-10-07
• Last Update Posted: 2011-10-10

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Patients having signs and symptoms of Tamaka Shwasa as described in Ayurvedic classics.
• Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.
• Symptoms/exacerbation (Wheeze, cough and breathlessness) more than once a week but less than once a day in frequency.

Exclusion Criteria

• 1.Age more than 60 years and below 16 years.
• 2.Mild intermittent, Moderated persistent, severe persistent to severe Asthma.
• 3.Dyspnoea resulting from other diseases like left ventricular failure, COPD (Chronic Bronchitis, Emphysema), upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc.
• 4.Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions.
• conditions in which urination is markedly diminished or excessive were excluded.
• 6.HIV positive cases.
• 7.Pregnant/lactating mother.
• 8.Patients having classical symptoms of Maha, Urdha, Chinna and Kshudra Shwasa.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Changes in the cardinal symptoms of Tamaka shwasa.	0, 4 weeks
2. Changes in ACQ and ACT score and PEFR.	0, 4 weeks

Secondary Outcome Measures

Name	Time	Method
Respiratory rate and Breath holding time	0, 4 weeks

Trial Locations

Locations (1)

Department of Rasa shastra and Bhaishajya kalpana; 🇮🇳 Jamnagar, GUJARAT, India

Department of Rasa shastra and Bhaishajya kalpana

🇮🇳Jamnagar, GUJARAT, India

Roshy Joseph C

Principal investigator

9624775660

himaroshy@gmail.com